Royalty Pharma plc
RPRX · FY2023
CEO Package
$0
Pay Ratio
—
Pablo Legorreta
CEO earned $0 in cash salary while stock price rose 28% — all wealth tied to share performance.
ELI LILLY & Co
LLY · FY2025
CEO Package
$30.2M
Pay Ratio
—
David A. Ricks
Returns outran pay growth by +3.5 pts
JOHNSON & JOHNSON
JNJ · FY2025
CEO Package
$32.8M
Pay Ratio
—
J. Duato
Returns outran pay growth by +16.0 pts
All values are grant-date fair value as reported in proxy statements.
The fastest way to read this comparison before dropping into the tables.
Latest CEO package mix by company. This stays on the CEO package even if the chart above is showing Top 5 pay.
RPRX
Pablo Legorreta
$0
LLY
David A. Ricks
$30.2M
JNJ
J. Duato
$32.8M
| Company | CEO | Latest Year | Total Comp |
|---|---|---|---|
| Royalty Pharma plc(RPRX) | N/A | 2024 | N/A |
| ELI LILLY & Co(LLY) | David A. Ricks | 2025 | $30.2M |
| JOHNSON & JOHNSON(JNJ) | J. Duato | 2025 | $32.8M |
Note: All compensation values shown are grant-date fair value as reported in proxy statements. Direct comparisons should account for differences in company size, industry, and compensation structure.
Want to know when these numbers change?
We’ll email you when these companies file a new proxy — so you can see how CEO pay, equity awards, and ratios shift before the next headline.